Tenofovir: all 281 studies that test it
Page 2 of 3. Open to participants first (11), then studies with results posted, then the rest; newest registration first within each.
- Pharmacokinetics of Two Formulation of Tenofovir Disoproxil FumarateCompletedNCT04671563Phase 4
- HIV Pre-exposure Prophylaxis Implementation Study in South KoreaStatus unknownNCT04583267Not applicable
- Entecavir and Tenofovir Versus Entecavir in Lymphoma Patients With Positive HBV DNAStatus unknownNCT04539119Phase 3
- ADORE: Efficacy of DORavirine in Adults Living With HIV Experiencing Virological Failure on First-line Efavirenz-based Antiretroviral Therapy With NNRTI ResistanceStatus unknownNCT04429152Phase 3
- A RCT of TNF and ENT in the Treatment of Long-term Prognosis With Hepatitis B-related HCC After Curative ResectionStatus unknownNCT04392700Phase 3
- Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in ColombiaCompletedNCT04359095Phase 2/3
- Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare PersonnelCompletedNCT04334928Phase 3
- Accelerated PrEP Access for Black MSM and TWWithdrawnNCT04329442Not applicable
- Development of a Urine-Based Point-of-Care Test for Adherence to Antiretroviral DrugsCompletedNCT04302896Early Phase 1
- Defining the PrEP Care Continuum Among Recently Incarcerated Men at High-Risk for HIV InfectionStatus unknownNCT04240509Phase 4
- Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Chronic Hepatitis bStatus unknownNCT04195074Not applicable
- An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Entecavir or Tenofovir in Patients With Chronic Hepatitis b Who Have Received Nucleoside (Acid) TherapyStatus unknownNCT04157257Phase 2
- Tenofovir in Pregnancy to Prevent Mother to Child Transmission of Hepatitis B.CompletedNCT04114890Phase 2
- RCT of Different Effects of Nucleot(s)Ide Analogues on the Prognosis of HBV-HCC Patients After Curative ResectionActive, not recruitingNCT04032860Phase 4
- Nucleosides And Darunavir/Dolutegravir In AfricaStatus unknownNCT03988452Phase 3
- The CHAPS Trial: Combined HIV Adolescent PrEP and PreventionCompletedNCT03986970Phase 2
- Combination Antiretroviral Therapy (cART) for PBCCompletedNCT03954327Phase 2
- Optimized Treatment of Peginterferon Alfa 2a/2b in Treatment Experienced Patients With HBV Related Liver FibrosisStatus unknownNCT03920605Not applicable
- Study of the Efficacy and Safety of HS-10234 in Patients With Chronic Hepatitis B Virus InfectionCompletedNCT03903796Phase 3
- Pre-Exposure Prophylaxis Dosing in Pregnancy to Optimize HIV Prevention (PREP-P)WithdrawnNCT03834909Phase 1
- Single Dose Truvada StudyCompletedNCT03719053Phase 1
- Body Composition Sub-study of the D2EFT TrialCompletedNCT03675815Phase 4
- Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - PK StudyCompletedNCT03652623Phase 1/2
- A Study in Healthy VolunteersCompletedNCT03596697Phase 1
- Evaluate the Efficacy and Safety to Tenofovir Disoproxil in Chronic Hepatitis B PatientsCompletedNCT03485534Phase 4
- Tenofovir Disoproxil Fumarate in Combination of Hepatitis B Vaccine for Preventing Hepatitis B Vertical TransmissionStatus unknownNCT03476083Phase 4
- The Safety of Anti-viral Therapy in Preventing HBV MTCT in Pregnant Women After DiscontinuationCompletedNCT03468907Phase 4
- The Kampala Women's Bone StudyCompletedNCT03464266Phase 4
- Antiviral Prophylaxis and Infant Vaccination to Prevent Perinatal Hepatitis B InfectionActive, not recruitingNCT03343431Phase 3
- Western Australian Pre-exposure Prophylaxis for HIV Implementation TrialCompletedNCT03327155Phase 3
- Bioequivalence Study of Two Formulatiosns With the Asscociaton of Efavirenz, Emtricitabine and TenofovirCompletedNCT03309566Phase 4
- Reverse Transcriptase Inhibitors in Aicardi Goutières SyndromeWithdrawnNCT03304717Phase 1/2
- A Pharmacokinetic Evaluation of Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis in Transgender WomenCompletedNCT03270969Phase 1
- Switching TDF/FTC/EFV to TDF/FTC/RPV VS Continuing TDF/FTC/EFV in HIV Patients With Complete Virological SuppressionCompletedNCT03251690Not applicable
- Tenofovir Monotherapy in Patients With Chronic Hepatitis B Patients Who Had Achieved Complete Viral Suppression on Lamivudine Plus AdefovirStatus unknownNCT03236584Phase 3
- The Incidence of Postpartum Hepatitis in Pregnant Women With Chronic Hepatitis B Virus InfectionStatus unknownNCT03214302Not applicable
- RIFT: Effect of Rifampicin on Plasma PK of FTC, TAF and Intracellular TFV-DP & FTC-TPCompletedNCT03186482Phase 1
- The Stay Study: A Demonstration Project Advancing PrEP Delivery in the San Francisco Bay Area Transgender CommunityCompletedNCT03120936Phase 4
- Evaluating the Feasibility and Acceptability of Implementing a PrEP Program in PR-CoNCRA (San Juan, Puerto Rico)- Part BStatus unknownNCT03120494Phase 4
- Prevention of HIV in "Île-de-France"Status unknownNCT03113123Not applicable
- Finding the Right Tenofovir/Emtricitabine Regimen for Pre-Exposure Prophylaxis (PrEP) in Transgender WomenCompletedNCT03060785Phase 1
- Study of the Relative Oral Bioavailability of AL-3778 Tablets and Drug Interaction With Entecavir or Tenofovir Disoproxil Fumarate in Healthy VolunteersTerminatedNCT03032536Phase 1
- Tenofovir in Early Pregnancy to Prevent Mother-to-child Transmission of Hepatitis B VirusCompletedNCT02995005Phase 1/2
- Dosing of Tenofovir and Efavirenz in Antiretroviral TherapyCompletedNCT02945163Phase 4
- Tenofovir As Prevention Of Hepatitis b Mother-to-child TransmissionStatus unknownNCT02937779Phase 4
- Optimization of Antiretroviral TherapyCompletedNCT02935075Phase 4
- A Randomized, Open-label, Single-dosing, 2X2 Crossover Study to Compare the Safety and Pharmacokinetics of BR-TND Tablet(Tenofovir Disoproxil) With Viread Tablet(Tenofovir Disoproxil Fumarate) in Healthy Male VolunteersCompletedNCT02920931Phase 1
- Expanded PrEP Implementation in Communities in NSWCompletedNCT02870790Phase 3
- A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBVCompletedNCT02751996Phase 2
- Dose Optimisation of Stavudine for the Treatment of HIV InfectionCompletedNCT02670772Phase 3
- Immediate Initiation of Antiretroviral Therapy During "Hyperacute" HIV InfectionActive, not recruitingNCT02656511Phase 4
- ART Drug Dosage Adjustment in HIV-infected PopulationCompletedNCT02632474Phase 4
- Use of TDF in Patients With Inactive Chronic Hepatitis B InfectionCompletedNCT02600117Phase 3
- HIV PrEP Priming of Immune EffectorsStatus unknownNCT02593409Phase 4
- To Compare the Efficacy of a Prophylactic Use of Tenofovir by Duration for the Non-Hodgkin's LymphomaStatus unknownNCT02585947Phase 4
- Bioequivalence Study of Two Formulations With the Association of Tenofovir 300 mg and Emtricitabine 200 mg.CompletedNCT02583464Phase 1
- An Exploratory Study of RGT Strategy on Optimal NUC-experienced PatientsStatus unknownNCT02560649Phase 4
- Clinical Trial to Assess the Safety and Pharmacokinetics of DA-2802 319mg and Viread 300mg in Healthy Male VolunteersCompletedNCT02557594Phase 1
- DAAs Treatment for Chronic HCV/HBV Co-infection Patients(DASCO)CompletedNCT02555943Phase 2/3
- A Study to Evaluate the Pharmacokinetics of Rilpivirine/Tenofovir/Emtricitabine After a Single-Oral Administration in Healthy Japanese Adult Male ParticipantsCompletedNCT02530060Phase 4
- Optimal Time for Tenofovir Treatment of Anti-Hepatitis B Virus (HBV) During the PregnancyStatus unknownNCT02510963Not applicable
- Efficacy of HBV Vaccine in Consolidation of Nucleos(t)Ide Analogues TherapyCompletedNCT02505009Phase 4
- Cost-effectiveness of Different Antiretroviral Treatment in Patients HIV NaiveWithdrawnNCT02470650Phase 4
- Roll-over After 3-year Trial for Tenofovir in Mild Chronic Hepatitis BStatus unknownNCT02463019Phase 4
- 'Tenofovir Pulse and Peg Interferon Alpha 2b' Therapy in HBeAg-positive Patients With Normal ALTWithdrawnNCT02454764Not applicable
- Decrease of Neuropsychiatric Side Effects After Switching From Atripla to EvipleraTerminatedNCT02447016Phase 4
- TDF and LdT in Immune-tolerant CHB Patients Awaiting Assisted ReproductionCompletedNCT02338674Phase 1/2
- Prompt Or Watchful Monitoring for Hepatitis B Virus Related Hepatocellular Carcinoma Without Elevated viRal LoadStatus unknownNCT02308319Phase 4
- Efavirenz to Dolutegravir Switch in Patients With CNS ToxicityStatus unknownNCT02285374Phase 4
- Comparison of Tenofovir Vaginal Gel and Film FormulationsCompletedNCT02280109Early Phase 1
- Raltegravir Versus Efavirenz in Naive HIV-1-infected Patients Receiving Rifampin for Active TuberculosisCompletedNCT02273765Phase 3
- A Trial Comparing Entacavir and Tenofovir in Patients With HBV Decompensated CirrhosisStatus unknownNCT02238860Phase 4
- Comparison of Two Combinations in Antiretroviral Post-Exposure Prophylaxis for HIV-1: Tenofovir/Emtricitabine (Truvada ®) + Lopinavir/Ritonavir (Kaletra ®) vs Tenofovir/Emtricitabine/Cobicistat/Elvitegravir (Stribild ®). Prospective, Randomized, Open.CompletedNCT02198443Phase 4
- Tenofovir to Prevent HBV ReactivationStatus unknownNCT02186574Phase 3
- PRe-Exposure Prophylaxis Acceptability & Readiness Assessments for Toronto gaY, Bisexual and Other Men Who Have Sex With Men-5CompletedNCT02149888Phase 4
- Switch From Nevirapine-based Regimen to Once a Day Rilpivirine/Emtricitabine/TenofovirCompletedNCT02104700Phase 2/3
- Tenofovir Abacavir Platelet Activation StudyCompletedNCT02093585Phase 4
- Prevention of Hepatitis B Virus Vertical Transmission by Serovaccination and Tenofovir During PregnancyCompletedNCT02039362Phase 4
- A Feasibility Study to Assess Tenofovir and Maraviroc Protection Against HIV-1 in Cervical and Vaginal ExplantsCompletedNCT02039323Phase 1
- A Randomized Controlled Trial on the Efficacy of Tenofovir Disoproxil Fumarate (TDF)-Switch Therapy in Chronic Hepatitis B Patients With Incomplete Response to EntecavirCompletedNCT01918631Not applicable
- Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular CarcinomaTerminatedNCT01872988Phase 3
- Tenofovir Versus Lamivudine for Patients of Chronic Hepatitis B With Severe Acute ExacerbationStatus unknownNCT01848743Phase 3
- In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal ProductsCompletedNCT01813162Phase 1
- Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited SettingCompletedNCT01772940Phase 4
- TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNACompletedNCT01732367Phase 4
- To Compare the Efficacy of Combined Tenofovir Plus Telbivudine vs Tenofovir Alone in Patients With Spontaneous Reactivation of Hepatitis BCompletedNCT01732224Not applicable
- Tenofovir in Asian Chronic Hepatitis B PatientsCompletedNCT01728935Not applicable
- Tenofovir Disoproxil Fumarate vs. Entecavir in Chronic Hepatitis B Patients With Partial Virologic Response to EntecavirCompletedNCT01711567Phase 4
- A Pilot Study to Assess the Feasibility of Switching, Individuals Receiving Atripla With Continuing Central Nervous System (CNS) Toxicity, to a Fixed Dose Combination of Tenofovir/Emtricitabine/RilpivirineCompletedNCT01701882Phase 3
- Economic, Clinical and Quality of Life Assessment in Patients on Antiretroviral TherapyCompletedNCT01694017Phase 4
- Coital Pharmacokinetics/Pharmacodynamics (PK/PD) of Tenofovir GelCompletedNCT01687205Phase 1
- A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis BCompletedNCT01671787Phase 1
- MARCH Renal SubstudyCompletedNCT01637259Phase 4
- Differences Between Stavudine and Tenofovir Each Combined With Lamivudine and Efavirenz in SA HIV-infected PatientsTerminatedNCT01601899Phase 4
- Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus InfectionStatus unknownNCT01594905Phase 4
- A Study of Drug-Drug Interaction Between Danoprevir Coadministered With Low-Dose Ritonavir and Tenofovir Disoproxil Fumarate or AtazanavirCompletedNCT01592305Phase 1
- Efficacy of Telbivudine With or Without add-on Tenofovir According to Roadmap Strategy Compare With EntecavirStatus unknownNCT01588912Phase 4
- The Mochudi Prevention Project ART ProtocolTerminatedNCT01583439Not applicable
- Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir (RAL-PEP)CompletedNCT01576731Phase 4
- Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC (MARAVI-PEP)CompletedNCT01533272Phase 4